Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL)

被引:40
|
作者
Sasayama, Takashi [1 ]
Tanaka, Kazuhiro [1 ]
Mizowaki, Takashi [1 ]
Nagashima, Hiroaki [1 ]
Nakamizo, Satoshi [1 ]
Tanaka, Hirotomo [1 ]
Nishihara, Masamitsu [2 ]
Mizukawa, Katsu [1 ]
Hirose, Takanori [3 ]
Itoh, Tomoo [4 ]
Kohmura, Eiji [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo, Japan
[2] Nishi Kobe Med Ctr, Dept Neurosurg, Kobe, Hyogo, Japan
[3] Kobe Univ Hosp, Dept Pathol Reg Commun, Kobe, Hyogo, Japan
[4] Kobe Univ Hosp, Diagnost Pathol, Kobe, Hyogo, Japan
关键词
cerebrospinal fluid; IL-10; primary central nervous system lymphoma; prognosis; tumor-associated macrophage; POOR-PROGNOSIS; SCAVENGER RECEPTOR; CELL LYMPHOMA; PROGRESSION; EXPRESSION; STAT3; INFILTRATION; SUPPRESSION; ACTIVATION; DIVERSITY;
D O I
10.1111/bpa.12318
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Increased tumor-associated macrophages (TAMs) have been reported to be associated with poor prognosis in various tumors; however, the importance of TAMs in primary central nervous system lymphoma (PCNSL) has not been clarified. In 47 patients with PCNSL who were treated with high-dose methotrexate (MTX) and radiotherapy, the relationships between the infiltration levels of TAMs and the clinicopathological parameters were analyzed. Univariate analysis of the Cox proportional hazards model using continuous scales revealed that increased CD68 positive (+) TAMs was significantly associated with inferior progression-free survival (PFS) (P=0.04), and trends were observed for the increased CD163(+)TAMs and having shorter PFS (P=0.05). However, increased TAMs were not associated with overall survival. Because TAMs are known to produce various cytokines, we examined the relationships between cerebrospinal fluid (CSF) cytokines and TAMs. CSF interleukin-6 (IL-6) and soluble IL-2 receptor were not correlated with the infiltration rate of TAMs; however, CSF IL-10 level was correlated with infiltration levels of CD68 and CD163(+)TAMs. We also confirmed the expression of IL-10 in CD68(+)and CD163(+)TAMs by double immunostaining analysis. Our results indicate that a high level of IL-10 in CSF may be positively associated with the infiltration level of TAMs in PCNSLs.
引用
收藏
页码:479 / 487
页数:9
相关论文
共 50 条
  • [41] Lenalidomide in the treatment of relapsed primary central nervous system lymphoma (PCNSL).
    Houillier, Caroline
    Choquet, Sylvain
    Touitou, Valerie
    Martin-Duverneuil, Nadine
    Khe Hoang-Xuan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Relapse and late neurotoxicity in primary central nervous system lymphoma (PCNSL)
    Abrey, LE
    Yahalom, J
    DeAngelis, LM
    NEUROLOGY, 1997, 48 (03) : V1003 - V1003
  • [43] Neurotoxicity as a result of treatment for primary central nervous system lymphoma (PCNSL)
    Omuro, AMP
    DeAngelis, LM
    Panageas, KS
    Ben-Porat, L
    Yahalon, J
    Abrey, LE
    NEUROLOGY, 2004, 62 (07) : A478 - A479
  • [44] A Series of Patients with Primary Central Nervous System Lymphoma (PCNSL) and AIDS
    Eisenstein, J. E.
    Mosunjac, M. B.
    LABORATORY INVESTIGATION, 2010, 90 : 333A - 333A
  • [45] PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) TREATED ONLY WITH CHEMOTHERAPY
    Abe, Tatsuya
    Sugita, Kenji
    Morishige, Masaki
    Momii, Yasutomo
    Anan, Mitsuhiro
    Murata, Kumi
    Kamida, Tohru
    Hikawa, Takamitsu
    Fujiki, Minoru
    Kobayashi, Hidenori
    NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 635
  • [46] Recurrent primary central nervous system lymphoma (PCNSL) treated with pemetrexed
    Altman, J. K.
    Gallot, L.
    Cohn, R.
    Chandler, J.
    Levy, R.
    Getch, C.
    Marymont, M.
    Tellez, C.
    Raizer, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Systemic relapse following primary central nervous system lymphoma (PCNSL)
    Moore, DF
    Rosenfeld, MR
    Abrey, LE
    NEUROLOGY, 1998, 50 (04) : A270 - A270
  • [48] LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
    Houillier, C.
    Choquet, S.
    Touitou, V.
    Martin-Duverneuil, N.
    Hoang-Xuan, K.
    NEURO-ONCOLOGY, 2014, 16
  • [49] A Series of Patients with Primary Central Nervous System Lymphoma (PCNSL) and AIDS
    Eisenstein, J. E.
    Mosunjac, M. B.
    MODERN PATHOLOGY, 2010, 23 : 333A - 333A
  • [50] Biological activity of interleukin-10 in the central nervous system
    Zocchia, C
    Spiga, G
    Rabin, SJ
    Grekova, M
    Richert, J
    Chernyshev, O
    Colton, C
    Mocchetti, I
    NEUROCHEMISTRY INTERNATIONAL, 1997, 30 (4-5) : 433 - 439